Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs1084909 | chr17:3232127 | C/T | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
| PCPG | rs10849191 | chr12:5114297 | C/T | 3.06E-5 | 176 | 25.53 | 24.1 | 14.4 | KM Plot |
| PCPG | rs10849466 | chr12:6582278 | T/C | 0.000279 | 177 | 19.3 | 25.97 | 25.17 | KM Plot |
| PCPG | rs10849927 | chr12:111587930 | A/G | 1.99E-5 | 171 | 25.92 | 20.47 | 16.68 | KM Plot |
| PCPG | rs10857480 | chr10:50591097 | G/A | 4.44E-6 | 174 | 24.53 | 34.93 | 25.17 | KM Plot |
| PCPG | rs10865585 | chr3:80591000 | T/A | 0.000124 | 177 | 19.87 | 24.03 | 27.4 | KM Plot |
| PCPG | rs10865586 | chr3:80591197 | C/T | 0.000119 | 178 | 27.2 | 24.03 | 19.87 | KM Plot |
| PCPG | rs10865587 | chr3:80591228 | C/T | 0.000124 | 177 | 19.87 | 24.03 | 27.4 | KM Plot |
| PCPG | rs1087082 | chr3:53506282 | C/T | 0.000243 | 172 | 31.43 | 24.5 | 25.53 | KM Plot |
| PCPG | rs10876405 | chr12:53500021 | C/T | 1.19E-10 | 175 | 25 | 27.08 | 3.05 | KM Plot |
| PCPG | rs10876406 | chr12:53501437 | T/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
| PCPG | rs10876408 | chr12:53502811 | A/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
| PCPG | rs10876409 | chr12:53502889 | C/T | 1.3E-10 | 173 | 25.17 | 27.08 | 3.05 | KM Plot |
| PCPG | rs10888941 | chr1:56333935 | T/G | 3.6E-7 | 170 | 25 | 25.77 | 13.27 | KM Plot |
| PCPG | rs10888942 | chr1:56335432 | C/G | 2.01E-7 | 174 | 25.7 | 25.67 | 13.27 | KM Plot |